perfusion < pergolide < pericentromeric

Facettes :

List of bibliographic references indexed by pergolide

Number of relevant bibliographic references: 17.

Ident.	Authors (with country if any)	Title
001049 (2005)	Katherine Grosset [Royaume-Uni] ; Donald Grosset [Royaume-Uni] ; Andrew Lees [Royaume-Uni]	Trial of subtherapeutic pergolide in de novo Parkinson's disease
001158 (2005)	Ron Tintner [États-Unis] ; Prasad Manian [États-Unis] ; Polly Gauthier [États-Unis] ; Joseph Jankovic [États-Unis]	Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson disease
001609 (2002)		DA agonists ‐ Ergot derivaties: Pergolide
001621 (2002)	M Ulivelli [Italie] ; S Rossi [Italie] ; C Lombardi [Italie] ; S Bartalini [Italie] ; R Rocchi [Italie] ; F Giannini [Italie] ; S Passero [Italie] ; N Battistini [Italie] ; E Lugaresi [Italie] ; David Rye [Italie] ; Joseph Jankovic [Italie]	Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Editorial
001758 (2001)	P Hanna [États-Unis] ; L Ratkos [États-Unis] ; W Ondo [États-Unis] ; J Jankovic [États-Unis]	Switching from pergolide to pramipexole in patients with Parkinson's disease
001875 (2000)	A Strafella [Italie] ; F. Valzania [Italie] ; S Nassetti [Italie] ; A. Tropeani [Italie] ; A. Bisulli [Italie] ; M. Santangelo [Italie] ; C Tassinari [Italie]	Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study
001A06 (1999)	J Sharma [Royaume-Uni, Niger] ; I Ross [Royaume-Uni]	Long term role of pergolide as an adjunct therapy in Parkinson's disease: influence on disability, blood pressure, weight and levodopa syndrome
001C52 (1996)	J Boas [Danemark] ; J Worm [Danemark] ; E Dupont [Danemark] ; B Mikkelsen [Danemark] ; L. Wermuth [Danemark]	The levodopa dose‐sparing capacity of pergolide compared with that of bromocriptine in an open‐label, crossover study
001D28 (1995)	Bonnet [France] ; I Serre [France] ; R Marconi [France] ; Y Agid [France] ; B Dubois [France]	A “combined” levodopa test as a useful method for evaluating the efficacy of dopamine agonists: Application to pergolide and bromocriptine
001D52 (1994)	Pezzoli [Italie] ; E Martignoni [Italie] ; C Pacchetti [Italie] ; V Angeleri [Italie] ; P Lamberti [Italie] ; A Muratorio [Italie] ; U Bonuccelli [Italie] ; M De [Italie] ; N Foschi [Italie] ; E Cossutta [Italie] ; F Nicoletti [Italie] ; F Giammona [Italie] ; M Canesi [Italie] ; G Scarlato [Italie] ; T Caraceni [Italie] ; E Moscarelli [Italie]	Pergolide compared with bromocriptine in Parkinson's disease: A multicenter, crossover, controlled study
001D80 (1994)	Olanow [États-Unis] ; S Fahn [États-Unis] ; M Muenter [États-Unis] ; H Klawans [États-Unis] ; H Hurtig [États-Unis] ; M Stern [États-Unis] ; I Shoulson [États-Unis] ; R Kurlan [États-Unis] ; J Grimes [Canada] ; J Jankovic [États-Unis] ; M Hoehn [États-Unis] ; C Markham [États-Unis] ; R Duvisin [États-Unis] ; O Reinmuth [États-Unis] ; H Leonard [États-Unis] ; E Ahlskog [États-Unis] ; R Feldman [États-Unis] ; L Hershey [États-Unis] ; M Yahr [États-Unis]	A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease
001D82 (1994)	C Olanow [États-Unis] ; S Fahn ; M Muenter ; H Klawans ; H Hurtig ; M Stern ; I Shoulson ; R Kurlan ; J Grimes ; J Jankovic ; M Hoehn ; C Markham ; R Duvoisin ; O Reinmuth ; H Leonard ; E Ahlskog ; R Feldman ; L Hershey ; M Yahr	A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet® in Parkinson's disease
001E69 (1991)		▾ Pergolide (celance) – a third dopamine agonist
001F53 (1988-04-01)	S Factor [États-Unis] ; J Sanchez [États-Unis] ; W Weiner [États-Unis]	Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.
001F74 (1987)	Joseph Jankovic [États-Unis] ; J. Orman	Parallel double-blind study of pergolide in Parkinson's disease.
002016 (1985)	J Jankovic	Long-term study of pergolide in Parkinson's disease
002024 (1983)	Joseph Jankovic [États-Unis]	Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "pergolide" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "pergolide" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    JankovicV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    pergolide
}}

---

This area was generated with Dilib version V0.6.19. Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024